ontrary to the popular belief that epilepsy is mainly a disease of youth, nearly 25% of new-onset seizures occur after age 65.
A seizure diagnosis carries significant implications in older people, who are already vulnerable to cognitive decline, loss of functional independence, driving restrictions, and risk of falls. Newly diagnosed epilepsy further worsens quality of life. 4 The causes and clinical manifestations of seizures and epilepsy in the elderly differ from those in younger people. 5 Hence, it is often difficult to make a diagnosis with certainty from a wide range of differential diagnoses. Older people are also more likely to have comorbidities, further complicating the situation.
Managing seizures in the elderly is also challenging, as age-associated physiologic changes can affect the pharmacokinetics and pharmacodynamics of antiepileptic drugs. Diagnosing and managing elderly-onset epilepsy can be challenging for a family physician, an internist, a geriatrician, or even a neurologist.
In this review, we emphasize the common causes of new-onset epilepsy in the elderly and the assessment of the clinical clues that are essential for making an accurate diagnosis. We also review the pharmacology of antiepileptic drugs used in old age and highlight the need for psychological support for patients and caregivers.
■ RISING PREVALENCE IN THE ELDERLY
In US Medicare beneficiaries age 65 and older, the average annual incidence rate of epilepsy in 2001 to 2005 was 10.8 per 1,000. 6 A large study in Finland revealed falling incidence rates of epilepsy in childhood and middle age and rising trends in the elderly. 7 In the United States, the rates are higher in African Americans (18.7 per 1,000) and lower in Asian Americans and Native Americans (5.5 and 7.7 per 1,000) than in whites (10.2 per 1,000). 6 Incidence rates are slightly higher for women than for men and increase with age in both sexes and all racial groups.
Acute symptomatic seizure is also common in older patients. The incidence of acute seizures in patients over age 60 was estimated at 50 to 100 per 100,000 per year in one study. 7 The rate was considerably higher in men than in women. The study also found a 3.6% risk of experiencing an acute symptomatic seizure in an 80-year lifespan, which approaches that of developing epilepsy. 8 The major causes of acute symptomatic seizure were traumatic brain injury, cerebrovascular disease, drug withdrawal, and central nervous system infection.
■ CAUSES OF NEW-ONSET EPILEPSY IN THE ELDERLY
The most common causes of new-onset epilepsy in the elderly include cerebrovascular disease, metabolic disturbances, dementia, traumatic brain injury, tumors, and drugs.
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Cerebrovascular disease
In older adults, acute stroke is the most common cause, accounting for up to half of cases. 5, 12 Seizures occur in 4.4% to 8.9% of acute cerebrovascular events. 13, 14 The risk varies by stroke subtype, although all stroke subtypes, including transient ischemic attack, can be associated with seizure. 15 For example, although 1% to 2% of patients experienced a seizure within 15 days of a transient ischemic attack or a lacunar infarct, this risk was 16.6% after an embolic stroke. 15 Beyond this increased risk of "acute seizure" in the immediate poststroke period (usually defined as 1 week), the risk of epilepsy was also 20 times higher in the first year after a stroke.
14 However, seizures tend to occur within the first 48 hours after the onset of ischemic stroke. In subarachnoid hemorrhage, seizures generally occur within hours. 16 In a population-based study in Rochester, NY, 17 epilepsy developed in two-thirds of patients with seizure related to acute stroke. Two factors that independently predicted the development of epilepsy were early seizure occurrence and recurrence of stroke.
Interestingly, the risk of stroke was three times higher in older patients who had newonset seizure. 18 Therefore, any elderly person with new-onset seizure should be assessed for cerebrovascular risk factors and treated accordingly for stroke prevention.
Metabolic disturbances
Acute metabolic disorders are common in elderly patients because of multiple comorbidities and polypharmacy. Hypoglycemia and hyponatremia need to be particularly considered in this population. 19 Other well-documented metabolic causes of acute seizure, including nonketotic hyperglycemia, hypocalcemia, and uremic or hepatic encephalopathy, can all be considerations, albeit less specific to this age group.
Dementia
Primary neurodegenerative disorders associated with cognitive impairment, such as Alzheimer disease, are major risk factors for newonset epilepsy in older patients. 3, 5 Seizures occur in about 10% of Alzheimer patients. 20 Those who have brief periods of increased confusion may actually be experiencing unrecognized complex partial seizures. 21 A case-control study discovered incidence rates of epilepsy almost 10 times higher in patients who had Alzheimer disease or vascular dementia than in nondemented patients. 22 A prospective cohort study in patients with mild to moderate Alzheimer disease established that younger age, a greater degree of cognitive impairment, and a history of antipsychotic use were independent risk factors for new-onset seizures in the elderly. 23 Preexisting dementia also increases the risk of poststroke epilepsy. 24 
Traumatic brain injury
The most common cause of brain trauma in the elderly is falls. Subdural hematoma, which can occur in the elderly with trivial trauma or Common causes of epilepsy in the elderly: stroke, metabolic disturbances, dementia, traumatic brain injury, tumors, drugs sometimes even without it, needs to be considered. The risk of posttraumatic hemorrhage is especially relevant in patients taking anticoagulants.
Traumatic brain injury has a poorer prognosis in older people than in the young, 25 and it accounts for up to 20% of cases of epilepsy in the elderly. 26 Although no study has specifically addressed the longitudinal risk of epilepsy after traumatic brain injury in the elderly, a study in children and young adults revealed the risk was highest in the first year, with the increased risk persisting for more than 10 years.
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Brain tumors
Between 10% and 30% of new-onset seizures in the elderly are associated with tumor, typically glioma, meningioma, and brain metastasis. 28, 29 Seizures are usually associated more with primary than with secondary tumors, and more with low-grade tumors than high-grade ones. 
Drug-induced
Drugs and drug withdrawal can contribute to up to 10% of acute symptomatic seizures in the geriatric population. 5, 8, 29 The elderly are susceptible to drug-induced seizure because of a higher prevalence of polypharmacy, impaired drug clearance, and heightened sensitivity to the proconvulsant side effects of medications. 1 A number of commonly used drugs have been implicated, 31 including: Antibiotics such as carbapenems and high-dose penicillin Antihistamines such as desloratadine (Clarinex)
Pain medications such as tramadol (Ultram) and high-dose opiates Neuromodulators Antidepressants such as clomipramine (Anafranil), maprotiline (Ludiomil), amoxapine (Asendin), and bupropion (Wellbutrin). 32 Seizures also follow alcohol, benzodiazepine, and barbiturate withdrawal. 
Other causes
Paraneoplastic limbic encephalitis is a rare cause of seizures in the elderly. 34 It can present with refractory seizures, confusion, and behavioral changes with or without a known concurrent neoplastic disease.
Posterior reversible leukoencephalopathy syndrome, another rare consideration, can particularly affect immunosuppressed elderly patients. This syndrome is characterized clinically by headache, confusion, seizures, vomiting, and visual disturbances with radiographic vasogenic edema. 35 
■ CLINICAL PRESENTATION
The signs and symptoms of a seizure may be atypical in the elderly. Seizures more often have a picture of "epileptic amnesia," with confusion, sleepiness, or clumsiness, rather than motor manifestations such as tonic stiffening or automatism. 36, 37 Postictal states are also prolonged, particularly if there is underlying brain dysfunction. 38 All these features render the clinical seizure manifestations more subtle and, as such, more difficult for the uninitiated caregiver to identify.
Convulsive and nonconvulsive status epilepticus
Status epilepticus is defined as a single generalized seizure lasting more than 5 minutes or a series of seizures lasting longer than 30 minutes without the patient's regaining consciousness. 39 The greatest increase in the incidence of status epilepticus occurs after age 60. 40 It is the first seizure in about 30% of new-onset seizures in the elderly. 41 Mortality rates increase with age, anoxia, and duration of status epilepticus and are over 50% in patients age 80 and older. 40, 42 Convulsive status epilepticus is most commonly caused by stroke. 40 Absence status epilepticus can occur in elderly patients as a late complication of idiopathic generalized epilepsy related to benzodiazepine withdrawal, alcohol intoxication, or initiation of psychotropic drugs.
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Nonconvulsive status epilepticus manifests as altered mental status, psychosis, lethargy, or coma. [42] [43] [44] Occasionally, it presents as a more focal cognitive disturbance with aphasia or a neglect syndrome. 42, 45 Electroencephalographic correlates of nonconvulsive status epilepticus include focal rhythmic discharges, often arising from frontal or temporal lobes, or generalized spike or sharp and slow-wave activity. 46 Its management is challenging because of delayed diagnosis or misdiagnosis. The risk of death is higher in patients with severely impaired mental status or acute complications. 47 Brief periods of increased confusion in Alzheimer patients may be unrecognized seizures 
■ KEYS TO THE DIAGNOSIS Clinical history
A reliable history and description of the event from an eyewitness or a video recording of the event are invaluable to the diagnosis of epileptic seizure. Signs and symptoms that suggest the diagnosis include aura, ictal pallor, urinary incontinence, tongue-biting, and motor symptoms, as well as postictal confusion, drowsiness, and speech disturbance.
Electroencephalography
EEG is the most useful diagnostic tool in epilepsy. However, an interictal EEG reading (ie, between epileptic attacks) in an elderly patient has limited utility, showing epileptiform activity in only about one-fourth of patients. 49 Nonspecific EEG abnormalities such as intermittent focal slowing are seen in many older people even without seizure. 50 Also, normal findings on outpatient EEG do not rule out epilepsy, as EEG is normal in about one-third of patients with epilepsy, irrespective of age. 1, 49 Activation procedures such as hyperventilation and photic stimulation add little to the diagnosis in the elderly. 49 On the other hand, video-EEG monitoring is an excellent tool for evaluating possible epilepsy, as it allows accurate assessment of brain electrical activity during the events in question. Moreover, studies of video-EEG recording of seizures in elderly patients demonstrated epileptiform discharges on EEG in 76% of clinical ictal events. 50 Therefore, routine EEG is a useful screening tool, and inpatient video-EEG monitoring is the gold standard to characterize events of concern and distinguish between epileptic and nonepileptic or psychogenic seizures.
Other diagnostic studies
Brain imaging, preferably magnetic resonance imaging with contrast, should be done in every patient with possible epilepsy due to stroke, traumatic brain injury, or other structural brain disease.
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Electrocardiography helps exclude cardiac causes such as arrhythmia.
Blood testing. Metabolically provoked seizure can be distinguished by blood analysis for electrolytes, blood urea nitrogen, creatinine, glucose, calcium, magnesium, liver enzymes, and drug levels (eg, ethanol). A complete blood cell count with differential and platelets should also be done in anticipation of starting antiepileptic drug therapy.
Lumbar puncture for cell count, protein, glucose, stains, and cultures should be performed whenever meningitis or encephalitis is suspected.
Presentation of seizures may be atypical in the elderly, with confusion, sleepiness, or clumsiness rather than motor manifestations A sleep study with concurrent video-EEG monitoring may be required to distinguish epileptic seizures from sleep disorders.
Neuropsychological testing may help account for the degree of cognitive impairment present.
Risk factors for stroke should be assessed in every elderly person who has new-onset seizures, because the risk of stroke is high.
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FIGURE 1 shows the workup for an elderly patient with suspected new-onset epilepsy.
■ TREATING EPILEPSY IN THE ELDERLY Therapeutic challenges
Age-associated changes in drug absorption, protein binding, and distribution in body compartments require adjustments in drug selection and dosage. The causes and manifestations of these changes are typically multifactorial, mainly related to altered metabolism, declining plasma albumin concentrations, and increasing competition for protein binding by concomitantly used drugs.
The differences in the pharmacokinetics and pharmacodynamics of antiepileptic drugs depend on the patient's physical status, relevant comorbidities, and concomitant medications. 52 Renal and hepatic function may decline in an elderly patient; accordingly, precaution is needed in the prescribing and dosing of antiepileptic drugs.
Adverse effects from seizure medications are twice as common in elderly patients compared with younger patients. Ataxia, tremor, visual disturbance, and sedation are the most common.
1 Antiepileptic drugs are also harmful to bone; induced abnormalities in bone metabolism include hypocalcemia, hypophos-A patient with a high clinical suspicion for seizures should undergo an EEG and be referred to a neurologist or epileptologist Elderly patients tend to take multiple drugs, and some drugs can lower the seizure threshold, particularly antidepressants, antipsychotics, and antibiotics. 32 The herbal remedy ginkgo biloba can also precipitate seizure in this population. 54 Antiepileptic drugs such as phenobarbital, primidone (Mysoline), phenytoin (Dilantin), and carbamazepine (Tegretol) can be broadspectrum enzyme-inducers, increasing the metabolism of many drugs, including warfarin (Coumadin), cytotoxic agents, statins, cardiac antiarrhythmics, antihypertensives, corticosteroids, and other immunosuppressants. 55 For example, carbamazepine can alter the metabolism of several hepatically metabolized drugs and cause significant hyponatremia. This is problematic in patients already taking sodium-depleting antihypertensives. Age-related cognitive decline can worsen the situation, often leading to misdiagnosis or patient noncompliance. have minimal enzyme interaction, little protein binding, linear kinetics, a long half-life, a good safety profile, and a high therapeutic index. The goal of management should be to maintain the patient's normal lifestyle with complete control of seizures and with minimal side effects.
The only randomized controlled trial in new-onset geriatric epilepsy concluded that gabapentin (Neurontin) and lamotrigine (Lamictal) should be the initial therapy in such patients. 56 Trials indicate extended-release carbamazepine or levetiracetam (Keppra) can also be tried. 57 The prescribing strategy includes lower initial dose, slower titration, and a lower target dose than for younger patients. Intense monitoring of dosing and drug levels is necessary to avoid toxicity. If the first drug is not tolerated well, another should be substituted. If seizures persist despite increasing dosage, a drug with a different mechanism of action should be tried. 58 A patient with drug-resistant epilepsy (failure to respond to two adequate and appropriate antiepileptic drug trials 59 ) should be referred to an epilepsy surgical center for reevaluation and consideration of epilepsy surgery.
Patient and caregiver support is an essential component of management. New-onset epilepsy in the elderly has a significant effect on quality of life, more so if the patient is already cognitively impaired. It erodes selfconfidence, survival becomes difficult, and the condition is worse for patients who live alone. Driving restrictions further limit independence and increase isolation. Hence, psychological support programs can significantly boost the self-esteem and morale of such patients and their caregivers.
■ SPECIAL CONSIDERATION: EPILEPSY IN THE NURSING HOME
Certain points apply to the growing proportion of elderly who reside in nursing homes:
• Several studies in the United States and in Europe [60] [61] [62] suggest that this subgroup is at higher risk of polypharmacy and more likely to be treated with older antiepileptic drugs.
• Only a minority of these patients (as low as 42% in one study 60 ) received adequate monitoring of antiepileptic drug levels.
• The clinical characteristics and epileptic etiologies of these patients are less well defined.
Routine EEG is useful for screening, while inpatient video-EEG monitoring is the diagnostic gold standard Together, these observations highlight a particularly vulnerable population, at risk for medication toxicity as well as for undertreatment.
■ OUR KNOWLEDGE IS STILL GROWING
New-onset epilepsy, although common in the elderly, is difficult to diagnose because of its atypical presentation, concomitant cognitive impairment, and nonspecific abnormalities in routine investigations. But knowledge of its common causes and differential diagnoses makes the task easier. A high suspicion warrants referral to a neurologist or epileptologist.
Challenges to the management of seizures in the elderly include deranged physiologic processes, multiple comorbidities, and polypharmacy. No single drug is ideal for antiepileptic therapy in the elderly; the choice of drug is usually dictated by seizure type, comorbidities, and tolerance level. The treatment regimen in the elderly is more conservative, and the target dosage is lower than for younger adults. Emotional support of patient and caregivers should be an important aspect of management.
Our knowledge about new-onset epilepsy in the elderly is still growing, and future research should explore its diagnosis, treatment strategies, and care-delivery models. 
